Financials

  • Market Capitalization 345.72 M
  • Employee 213
  • Founded 1996
  • CEO N/A
  • Website www.simulations-plus.com
  • Headquarter North Carolina, United States
  • FIGI BBG000BS2ZD1
  • Industry Services d'Information sur la Santé
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.47
ratio cours/chiffre d'affaires
3.65
Dividende par action
Rendement du dividende (%)

Simulations Plus, Inc. - Common Stock

Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services.

Nouvelles